Gurgaon-based Startup Sova Health Secures Seed Funding
The investment was jointly led by global early-stage VC Antler, Accelerating Asia from Singapore, Practical VC from the US, and VC Grid & Venture Catalysts from India.
Gurgaon-based health startup Sova Health has closed a $1 million seed round.
The investment was jointly led by global early-stage VC Antler, Accelerating Asia from Singapore, Practical VC from the US, and VC Grid & Venture Catalysts from India.
The round also saw participation from Quadrant Consumer Products, Midas Capital (Baheti Family Office), and marquee angel investors.
The fresh infusion of funds will be utilized to fuel the company’s growth initiatives across three key areas including product development, team expansion, and market expansion.
On the deal, Tanveer Singh, cofounder and CEO, Sova Health said, "This investment marks a significant milestone for us as we continue to expand our product portfolio and reach. We are grateful for the support of our investors and look forward to leveraging this capital to drive innovation and make a positive impact in the gut health space. It's still day 0 in our mission to add a billion healthy years to the world."
Sova Health Offerings
This latest funding round follows the company’s earlier success in securing its pre-seed round from Goodwater Capital, Brinc, IIMA Ventures, and Stanford Angels, among others.
Reportedly, over the past 15 months, Sova Health has experienced exponential growth, achieving a tenfold increase in revenue.
Further, the startup has successfully launched a range of proprietary probiotic supplements, with close to 100,000 units sold.
Expressing thoughts, Max Kushnir, cofounder and chief science officer, Sova Health, said “We have built a proprietary database of the Indian microbiome, drawing from thousands of in-house gut microbiome tests. Using this data, we develop probiotics targeted at the Indian gut.”
Furthermore, Sova Health has developed a portfolio of products addressing a wide range of digestive health symptoms, including bloating, IBS, constipation, and overall gut health.
Vansh Oberoi, CIO, Venture Catalysts and managing partner, VC Grid said, “The field of digestive or gut-related healthcare is often neglected and underestimated in India, despite the fact that over 56% of the population, particularly in urban areas, experience chronic gut-related disorders. However, there has been a recent surge in consumer awareness regarding gut health, presenting a significant opportunity for Sova.”
Additionally, the company offers customized gut health programs for individuals with gastrointestinal conditions such as IBS, IBD, GERD, Crohn’s disease, chronic acidity, and constipation, among others.
Sharing his views, Craig Dixon, general partner, Accelerating Asia said, “This investment aligns with our strategy to support research-driven and tech-enabled health solutions. The company is scaling at an impressive pace due to the large market opportunity and the execution of the leadership team of Tanveer and Max."
With this latest funding, Sova Health aims to further enhance its product portfolio, launch a clinical trial for its DTx program, and further its position as a leading player in the gut health industry in India.
Jussi Salovaara, cofounder and managing partner, Antler, said, "This investment aligns with our vision to support founders who are solving critical health challenges with cutting-edge solutions."
